Rapid, efficient and accurate nucleic acid molecule detection is important in the screening of diseases and pathogens. Microfluidic systems are characterized by fast, integrated, miniaturized features that provide an effective platform for qualitative and quantitative detection of nucleic acid molecules. With experience in Microfluidic design and advanced Microfluidic platforms, Creative Biolabs is competent to offer the best-qualified nucleic acid detection and analysis services based on Microfluidic technology to meet our customers' specific requirements.
To provide real-time diagnosis of diseases and early screening for diseases, it is important to develop techniques that allow for accurate and rapid detection of nucleic acids. Differentiating by temperature control conditions, nucleic acid amplification techniques can be divided into isothermal and non-isothermal amplification techniques. Multiplex PCR assays, DNA microarrays, and various nanotechnology-based nucleic acid sensors are examples of major techniques developed for analyzing nucleic acids. However, these methods have several challenges such as lengthy preparation and analysis time, vulnerability to contamination, complex procedures and operation, and sensitivity limitations. The challenges limit its effectiveness in point-of-care (POC), especially in resource-limited settings. Integration of Microfluidic technology with nucleic acid extraction helps to address these technical and analytical limitations associated with nucleic acid detection.
Microfluidics-based approaches provide an ideal platform for nucleic acid amplification and rely mainly on fast prototyping by soft lithography in polydimethylsiloxane (PDMS) or glass. In recent years, many kinds of nucleic acid amplification approaches such as PCR and isothermal amplification have been performed on the Microfluidic system with the achievement of fast and accurate detection.
qPCR is a relative quantification technique that relies on a standard curve or reference gene assessment to determine the amount of target nucleic acid. For low copy number target analyte, issues such as primer efficiency and differences in template concentrations can markedly affect the detection sensitivity and accuracy at the end-stage.
Fig.1 A schematic diagram of Microfluidic digital PCR. (Streets, 2014)
The ease of operation, high specificity and high sensitivity make nucleic acid isothermal amplification a potential tool for POC. The nucleic acid isothermal amplification technology does not require different temperature cycles to generate new products from the nucleic acid template. It does not depend on sophisticated equipment and has shown good application prospects in POC. Among various isothermal amplification techniques, loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), and rolling circle amplification (RCA) has attracted significant attention from the Microfluidics community.
Microfluidics is increasingly being explored and validated for use in the detection and diagnosis for cancers from colorectal carcinoma, hepatocellular carcinoma, to prostate cancer and different types of infectious diseases from food-borne pathogen and Hepatitis B to meningitis and dengue virus, and other diseases from cardiovascular disease to Alzheimer's diseases.
Fig.2 Biomarker detection on Microfluidic platforms with chemiluminescence and electrochemiluminescence detection. (Sanjay, 2015)
Visual detection of pathogen nucleic acids also has broad applications in the detection of pathogen nucleic acids. For instance, an enzyme-assisted nano-complexes for visual identification of nucleic acids has been reported. The system consists of an integrated circuit of enzyme-DNA nanostructures, which function as independent recognition and signaling elements, for direct and versatile detection of pathogen nucleic acids from infected cells. When implemented on a configurable Microfluidic platform, the technology demonstrates superior programmability to perform versatile computations, for detecting diverse pathogen targets and their virus-host genome integration loci.
Fig.3 Visual and modular detection of pathogen nucleic acids. (Ho, 2018)
Creative Biolabs now offers Microfluidics-based nucleic acid detection and analysis services, including but not limited to:
With the high demand for rapid detection tools for diseases and pathogens in the fields of disease diagnosis, the focus has been directed towards molecular diagnostic approaches for POC. By virtue of its own technical advantages, Microfluidic systems have been developed and integrated to perform nucleic acid detection for diverse application. Creative Biolabs also provides Microfluidic-based POCT Development Services for global clients. If you are interested in our services or seeking cooperation, please feel free to contact us for more information.
For Research Use Only.